Skip to main content

Advertisement

Log in

Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin

  • PRECLINICAL STUDIES
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Summary

Malignant pleural mesothelioma is a fatal malignancy linked to asbestos exposure. The main challenge for mesothelioma treatment is to go beyond the drug resistance, in particular against cisplatin (CDDP), one of the most used chemotherapeutic drug. 3-O-methylfunicone (OMF) is a metabolite produced by the fungus Penicillium pinophilum; its antiproliferative properties have been previously studied in vitro. Particularly, OMF is able to inhibit mesothelioma cell motility. To improve the effects of CDDP by-passing the resistance of mesothelioma cells to this drug, in the present study we investigated the combined treatment of OMF with CDDP respectively in an established mesothelioma cell line (NCI) and primary mesothelioma cells (Mest). As compared to the effect of single treatments, the combination of OMF and CDDP resulted in a stronger inhibition of NCI and Mest cell proliferation. OMF combination with CDDP was also able to affect the migratory ability of NCI and Mest cells by down-regulating αv and β5 expression and reducing metalloproteinase 2 (MMP-2) production. In addition, this association was effective in modulating VEGF gene expression. This finding highlights the possibility to use OMF and CDDP together to regulate angiogenesis and tumour progression in mesothelioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Lee AY et al (2007) Update on the molecular biology of malignant mesothelioma. Cancer 109:1454–1461

    Article  CAS  PubMed  Google Scholar 

  2. Fennell DA et al (2008) Advances in system therapy of malignant mesothelioma. Nat Clin Pract Oncol 5:136–147

    Article  PubMed  Google Scholar 

  3. Vogelzang NJ et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636–2644

    Article  CAS  PubMed  Google Scholar 

  4. Montopoli M et al (2009) Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Cell Prolif 42:195–206

    Article  CAS  PubMed  Google Scholar 

  5. Newman DJ, Cragg G, Snader KM (2003) Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66:1022–1037

    Article  CAS  PubMed  Google Scholar 

  6. Nicoletti R, Ciavatta L, Buommino E, Tufano MA (2008) Antitumor extrolites produced by Penicillium species. Int J Biomed Pharm Sci 2:1–23

    Google Scholar 

  7. De Stefano S, Nicoletti R, Milone A, Zambardino S (1999) 3-O-Methylfunicone, a fungitoxic metabolite produced by the fungus Penicillium pinophilum. Phytochemistry 52:1399–1401

    Article  Google Scholar 

  8. Nicoletti R, De Stefano M, De Stefano S, Trincone A, Marziano F (2004) Identification of fungitoxic metabolites produced by some Penicillium isolates antagonistic to Rhizoctonia solani. Mycopathologia 158:465–474

    Article  CAS  PubMed  Google Scholar 

  9. Buommino E, Nicoletti R, Gaeta GM, Orlando M, Ciavatta ML, Baroni A et al (2004) 3-O-methylfunicone, a secondary metabolite produced by Penicillium pinophilum, induces growth arrest and apoptosis in HeLa cells. Cell Prolif 37:413–426

    Article  CAS  PubMed  Google Scholar 

  10. Buommino E, Boccellino M, De Filippis A, Cozza V, Nicoletti R, Ciavatta ML et al (2007) 3-O-methylfunicone by Penicillium pinophilum affects cell motility of breast cancer cells, down-regulating αVβ5 integrin and inhibiting MMP9 secretion. Mol Carcinog 46:930–940

    Article  CAS  PubMed  Google Scholar 

  11. Baroni A, De Luca A, De Filippis A, Petrazzuolo M, Manente L, Nicoletti R et al (2009) 3-O-methylfunicone, a metabolite from Penicillium pinophilum, inhibits proliferation of human melanoma cells by causing G2/M arrest and inducing apoptosis. Cell Prolif 42:541–553

    Article  CAS  PubMed  Google Scholar 

  12. Buommino E, Paoletti I, De Filippis A, Nicoletti R, Ciavatta ML, Menegozzo S, Menegozzo M, Tufano MA (2010) 3-O-Methylfunicone, a metabolite produced by Penicillium pinophilum, modulates ERK1/2 activity, affecting cell motility of human mesothelioma cells. Cell Prolif 43:114–123

    Article  CAS  PubMed  Google Scholar 

  13. Foster MR, Johnson JE, Olson SJ, Allred DC (2001) Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas. Arch Pathol Lab Med 125:1316–1320

    CAS  PubMed  Google Scholar 

  14. Szczepulska-Wojcik E, Langfort R, Roszkowski-Aliz K (2007) A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cellproliferation. Pneumonol Alergol Pol 75:57–69

    PubMed  Google Scholar 

  15. Woods D, Cherwinski H, Venetsanakos E, Bhat A, Gysin S, Humbert M et al (2001) Induction of b3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-Extracellular signal-regulated kinase signaling pathway. Mol Cell Biol 21:3192–3205

    Article  CAS  PubMed  Google Scholar 

  16. Lee YJ, Cho HN, Soh JW, Jhon GJ, Cho CK, Chung HY, Bae S, Lee SJ, Lee YS (2003) Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation. Exp Cell Res 291:251–266

    Article  CAS  PubMed  Google Scholar 

  17. Peto J, Decarli A, La Vecchia C et al (1999) The European mesothelioma epidemic. Br J Cancer 86:1970–1971

    Google Scholar 

  18. Le GV, Takahashi K, Karjalainen A, Delgermaa V, Hoshuyama T, Miyamura Y, Furuya S, Higashi T, Pan G, Wagner G (2010) National use of asbestos in relation to economic development. Environ Health Perspect 118:116–119

    PubMed  Google Scholar 

  19. Toyooka S, Kishimoto T, Date H (2008) Advances in the molecular biology of malignant mesothelioma. Acta Med Okayama 62:1–7

    CAS  PubMed  Google Scholar 

  20. Bertolini F, Paul S, Mancuso P, Monestiroli S, Gobbi A, Shaked Y, Kerbel RS (2003) Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells. Canc Res 63:4342–4346

    CAS  Google Scholar 

  21. Damber JE, Vallbo C, Albertsson P, Lennernäs B, Norrby K (2006) The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin. Cancer Chemother Pharmacol 58:354–360

    Article  CAS  PubMed  Google Scholar 

  22. Fusco V, Ardizzoni A, Merlo F, Cinquegrana A, Faravelli B, De Palma M, Chessa L, Nicolò G, Serra M, Capaccio A et al (1993) Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients. Anticancer Res 13:683–689

    CAS  PubMed  Google Scholar 

  23. Elbahaie AM, Kamel DE, Lawrence J, Davidson NG (2009) Late cutaneous metastases to the face from malignant pleural mesothelioma: a case report and review of the literature. World J Surg Oncol 7:84

    Article  PubMed  Google Scholar 

  24. Demiroglu-Zergeroglu A, Basara-Cigerim B, Kilic E, Yanikkaya-Demirel G (2010) The investigation of effects of Quercetin and its combination with cisplatin on malignant mesothelioma cells in vitro. J Biomed Biotechnol 2010:851589

    Article  CAS  PubMed  Google Scholar 

  25. Liu Z, Ivanoff A, Klominek J (2001) Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines. Int J Cancer 91:638–643

    Article  CAS  PubMed  Google Scholar 

  26. Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A (2001) Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol 193:468–475

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from Convenzione Registro Mesoteliomi-Regione Campania (2006–2008)

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Antonietta Tufano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buommino, E., De Filippis, A., Nicoletti, R. et al. Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin. Invest New Drugs 30, 1343–1351 (2012). https://doi.org/10.1007/s10637-011-9698-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-011-9698-1

Keywords

Navigation